Indexes remain range-bound, but IBD 50 stocks hold up. Plus, what to do between earnings seasons. Notes at investors.com/investingshow.

Several IBD 50 stocks set up in a still challening and range-bound market. Cybersecurity stocks like Palo Alto Networks and CyberArk head higher on news of a government network breach, while new IPO stocks David's Tea, Endochoice and Evolent Health make their debuts. Plus, what are the 3 key ingredients of big earnings growth - and does your stock have the right recipe? Notes at investors.com/investingshow.

Market remains range bound, but in uptrend. Plus, where to find stocks with big potential. Notes at investors.com/investingshow.

MarketSmith's Irusha Peiris on this year's market and how he's adjusted to fit current conditions. Notes at investors.com/investingshow.

Nasdaq sparks new uptrend as several leaders form bases. But if a bear hits, are you ready? Notes at investors.com/investingshow.

The rollercoaster market continues. Plus, 10 common mistakes and lessons learned from LinkedIn and Monster. Notes at investors.com/investingshow.

Indexes come under pressure as several top stocks stumble. Plus, how to adapt to the current market. Notes at investors.com/investingshow.

Market climbs, but are chips getting stale? Plus, how to review stocks like Twitter before they report earnings. Notes at investors.com/investingshow.

Market sells off, but IBD 50 stocks holding up so far. Plus, do you tend to sell too soon or too late? Notes at investors.com/investingshow.

Nasdaq testing 5,000 again, but questions remain. Plus, how to prepare for Q1 earnings season. Notes at investors.com/investingshow.